Many kidney failure patients are increasing their chance of nerve damage in their legs and feet by simply having too much potassium in their diet.
Read More »Early Glucose Challenge Testing Identifies Diabetes Versus Gestational Diabetes
In women in whom prenatal care is the first medical care they receive, screening for gestational diabetes before they are 24 weeks pregnant could help identify those with pre-gestational diabetes mellitus.
Read More »Discovery of Gene Plays Important Role in the Onset of Type 2 Diabetes
In a painstaking set of experiments, scientists have discovered a gene that appears to play an important role in the onset of type 2 diabetes.
Read More »Weight Loss Hurdle for Black Women Different Then for White Women
Scientists Spot Difference in Belly Fat of Black and White Obese Women
Read More »Novel System Helps Grade Diabetic Foot Ulcer Severity
A new wound-based measurement system, the diabetic ulcer severity score (DUSS), helps categorize such ulcers and their likely outcome.
Read More »Young Diabetics Not Meeting Diet Recommendations
Many adolescents and young adults with diabetes have diets that fall far short of what’s recommended to help manage their disease, according to a new study.
Read More »Grapefruit Juice Drug Interaction Culprit Identified
Those dangerous interactions when grapefruit juice is mixed with some drugs are apparently triggered by members of a family of plant toxins called furanocoumarins. Watch for the new Grapefruit juice to hit the supermarket shelves soon.
Read More »Exubera: So Far No Evidence Available of Additional Therapeutic Benefit
Germany publishes a report showing that there is no additional therapeutic benefits to replacing insulin administered subcutaneously.
Read More »Efficacy and Safety of Exubera Insulin Versus Injectable Insulin
The efficacy and safety of human insulin inhalation powder (HIIP) plus insulin glargine were compared to subcutaneously injected insulin (SC insulin) plus insulin glargine in patients with type 1 diabetes.
Read More »AACE: Higher Risk Patients Benefit More After Conversion from Rosiglitazone to P
AACE: Higher Risk Patients Benefit More After Conversion from Rosiglitazone to Pioglitazone A new study shows that conversion from rosiglitazone to pioglitazone while maintaining statin therapy, improves the lipid profiles in patients with type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.